ARCHIVES

FDA Consider Regulation of CME Programs Paid for By Drug Companies; Goal To Limit Promotion

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998

AIDS Vaccine Intervention Progress Reported

July 5, 1985

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

NCI Advisors To Gain Increased Responsibility For Concept, Technical Merit Review Of Contracts

December 19, 1980